Joerger, M., Stathis, A., Metaxas, Y., Hess, D., Mantiero, M., Mark, M., . . . von Moos, R. (2019). A Phase 1 study of BAL101553, a novel tumor checkpoint controller targeting microtubules, administered as 48-h infusion in adult patients with advanced solid tumors. Invest New Drugs.
Style de citation ChicagoJoerger, Markus, et al. "A Phase 1 Study of BAL101553, a Novel Tumor Checkpoint Controller Targeting Microtubules, Administered As 48-h Infusion in Adult Patients With Advanced Solid Tumors." Invest New Drugs 2019.
Style de citation MLAJoerger, Markus, et al. "A Phase 1 Study of BAL101553, a Novel Tumor Checkpoint Controller Targeting Microtubules, Administered As 48-h Infusion in Adult Patients With Advanced Solid Tumors." Invest New Drugs 2019.